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Abstract
Background: We aimed to estimate the effect of alcohol consumption on breast cancer risk and to test whether
overweight and obesity modifies this association.
Methods: We included in the analysis 45,233 women enrolled in the Swedish Women’s Lifestyle and Health study
between 1991 and 1992. Participants were followed for occurrence of breast cancer and death until December
2009. Poisson regression models were used, and analyses were done for overall breast cancer and for estrogen
receptor positive or negative (ER+, ER-) and progesterone receptor positive and negative (PR+, PR-) tumors
separately.
Results: A total of 1,385 breast cancer cases were ascertained during the follow-up period. Overall, we found no
statistically significant association between alcohol intake and breast cancer risk after adjustment for confounding,
with an estimated relative risk (RR) of 1.01 (95 % CI: 0.98–1.04) for an increment in alcohol consumption of 5 g/day.
A statistically significant elevated breast cancer risk associated with higher alcohol consumption was found only
among women with BMI ≤25 (RR 1.03, 95 % CI 1.0–1.05 per 5 g/day increase).
Conclusion: An increase in breast cancer risk with higher alcohol consumption was found for breast cancers in
women with a BMI ≤25 kg/m2.
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Background
The International Agency for Research on Cancer (IARC)
has classified alcohol as a human carcinogen [1] which
increases risk of breast cancer both before and after
menopause [2]. Alcohol consumption has been esti-
mated to account for 5 % of breast cancer incidence in
the European Prospective Investigation into Cancer and
Nutrition (EPIC) study [3]. Population attributable frac-
tion of alcohol on breast cancer mortality has been esti-
mated to be 6.4 % in the United Kingdom,[4] 9.4 % in
France,[5] and 6 % in the United States [6].
Several mechanisms have been proposed to explain
this association [2] increasing the probability that alco-
hol might play a causal role in breast cancer etiology.
According to one theory, alcohol increases circulating es-
trogen levels through interaction with estrogen metabol-
ism [7]. The same mechanism, augmented by decreased
levels of sex hormone binding globulin (SHBG) leading to
more available estrogen, is also proposed to explain why
obesity increases risk of postmenopausal breast cancer [8].
Before menopause, obese women experience a lower risk
for breast cancer than lean women; however, the opposite
is observed after menopause [2, 9]. The inverse association
between obesity and risk of premenopausal breast cancer
is less well understood mechanistically.
We hypothesized that if alcohol and obesity compete
via a similar mechanism to increase risk of postmeno-
pausal breast cancer, then these two exposures may not
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be additive. We further hypothesized that the possible
association between these exposures and breast cancer
may pertain chiefly or exclusively to hormone receptor
positive cancers. We tested our hypotheses in a large
prospective study in Sweden.
Methods
Study population
The study cohort comprised participants of the Swedish
Women’s Lifestyle and Health (WLH) study (http://
ki.se/en/meb/womens-lifestyle-and-health). Details of
the study design have been described elsewhere [10,
11]. The study enrolled women age 30–49 who resided
in the Uppsala Health Care Region. Among 49,259 women
who answered the baseline questionnaire in 1991 and
1992 we excluded 374 for the following reasons: death (n
= 68), emigration without re-immigration (n = 67), previ-
ous breast cancer diagnosis (n = 273), and uninterpret-
able answers to questionnaire (n = 2). We further
excluded 3,652 women with any missing value on se-
lected key covariates (age, birth year, weight, height, edu-
cation, family history of breast cancer, alcohol
consumption, smoking habit, age at menarche, meno-
pausal status, age at menopause, parity, age at the first
birth, breast feeding duration, and oral contraceptive use).
The final analytic cohort consisted of 45,233 women. Par-
ticipants were asked to report the number of glasses of
beer, wine, and spirits that she currently drank per week,
per month, or per year on the baseline questionnaire. On
the follow-up questionnaire, consumption frequency and
the amount of consumption on one occasion for low alco-
hol beer, beer, white wine, red wine, dessert wine, and
spirits were asked. Body mass index was calculated by
using the present height and weight reported on the base-
line questionnaire.
Complete follow-up was achieved through linkage to the
nationwide health registries in Sweden using the unique na-
tional registration number assigned to each individual.
Overall breast cancer incidence was obtained from the na-
tional register, and estrogen receptor (ER) and progesterone
receptor (PR) status of breast tumor was obtained from the
regional register. Incident invasive breast cancer (ICD7
170) was ascertained from the Swedish cancer register from
1st September 1992 when the regional breast cancer regis-
ter in Uppsala was set up, up to 31st December 2009. The
Swedish Data Inspection Board and the regional Ethical
Committee, Uppsala University, Uppsala, Sweden and the
Ethical Committee of the Karolinska Institutet in
Stockholm, Sweden approved the study protocol. All partic-
ipants signed an informed consent form.
Statistical analysis
We analyzed breast cancer risk associated with alcohol
consumption using Poisson regression. This was done
with alcohol intake modeled without any predefined
shape, with step-function using alcohol categories and
also as linear continuous form. To evaluate the func-
tional form between alcohol intake and breast cancer
incidence, we estimated the relative risk (RR) using
splines, i.e. log (cancer rate) = h (alcohol, gram/day)
where h () is an arbitrarily shaped curve. We fitted all
models adjusting for age and for other possible confound-
ing variables. Poisson regression is commonly used in
survival analysis and gives approximately the same param-
eter estimates and likelihood ratios as Cox proportional
hazards regression when the length of follow-up is split
into finer intervals (here we used 2 year intervals) [12, 13].
The details for the calculation of total alcohol intake
have been described previously [14]. Briefly, the reported
quantities of beer, wine, and spirits were converted to
grams of alcohol using food composition data from the
Swedish National Food Administration [14]. Total al-
cohol intake was categorized according to the distri-
bution of the variable in the WLH population as categories
(0, 0.1–5.0, 5.1–15, and >15 g/day), and as a continuous
variable. The category of 0–5 g of alcohol per day corre-
sponds to approximately 0 to 2 glasses of wine per week
(1 glass = 1 dl; alcohol by volume = 10 %). Age was in-
cluded as a categorical covariate.
We assessed the following potential confounding covari-
ates: educational attainment (0–11 years, >11 years), his-
tory of breast cancer in mother and/or sister(s) (Yes/No),
smoking habits (current, former, never smokers), physical
activity at enrollment with five grade scale, age at menar-
che (years), menopausal status (Yes/No), time varying
parity at baseline (0, 1, 2, 3, and >3), age at the first child
birth (years), breast feeding duration (month), and oral
contraceptive use (current/former/never). Age at the first
birth was modeled using, for nulliparous women, zero and
for parous women extracting the average age at the first
birth from the age at the first birth. Self-reported BMI was
categorized into two groups (<= 25 kg/m2 and >25 kg/
m2). Age at menopause and the use of hormone replace-
ment therapy (HRT) were both analyzed as time varying
variables using the combined 1991 and 2003 follow-up
data. Thus, women’s menopausal status and HRT use
could change along the follow-up period. Participants
were censored when death or immigration occurred after
entry into the cohort, or at 31st December 2009, which-
ever came first. The RR of breast cancer comparing differ-
ent groups of exposure and change in RR by level of
modifying covariates was estimated together with associ-
ated two-sided 95 % confidence intervals.
We fitted models, for breast cancer overall as well as
by ER/PR receptor status, and included parameters for
the main effects and the interaction term between BMI
(<= 25 kg/m2 and >25 kg/m2) and alcohol intake (0, 0–5,
5–15 and >15 g/day). We calculated RR for breast cancer
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comparing each combination of alcohol and BMI versus
low BMI and an alcohol intake of 0 g/day. In the same
model we tested the statistical hypothesis of no interaction
using a likelihood ratio test.
All statistical tests were two-sided with α= 0.05.
All models for overall breast cancer were repeated
for ER+/PR+, ER+/PR-, and ER-/PR- breast cancers sep-
arately. We did not separately analyze the ER-/PR+ tu-
mors owing to the small number.
Results
Baseline characteristics of study participants are pre-
sented in Table 1. High alcohol intake was more common
among women with high educational attainment, women
who were former or current smokers, women with few
children, and among those who had ever used oral contra-
ceptives. The proportion of women with BMI > 25 kg/m2
was highest among non-drinking women. In addition, the
alcohol intake was higher among women with BMI
≤25 kg/m2 (median = 2.6 g/day for BMI ≤25 kg/m2, me-
dian = 1.8 g/day for BMI > 25 kg/m2). During the follow-up
period, a total of 1,385 breast cancer cases were ascer-
tained. Among them, 718 tumors were ER+/ and PR +,
196 were ER+/PR-, 187 were ER -/PR- and 37 were
ER-/PR+. Table 2 shows breast cancer risk by alcohol
intake in the entire cohort as well as for different hor-
mone receptor subtypes. Alcohol intake was not statis-
tically significantly associated with breast cancer risk,
either overall or in different hormone receptor sub-
types. We did not find evidence of a non-linear relation
between alcohol intake and breast cancer incidence and
RR estimated by splines (data not shown).
Overall breast cancer risk increased with increasing alco-
hol intake among women with BMI ≤25 kg/m2 (RR = 1.03,
95 % CI: 1.00–1.05 per 5 g/day increase), but not among
women with BMI over 25 kg/m2. Similar patterns were ob-
served for all subtypes of breast cancer, but statistical tests
for interaction were significant only for ER-/PR- breast
cancer (p = 0.04) (Table 3).
Additional analysis with menopausal status as time-
varying variable or HRT use as time-varying variable did
not change the results (data not shown).
Discussion
After multivariable adjustment we did not observe a sta-
tistically significant risk of breast cancer in the com-
bined group of lean and overweight women. However,
we found that high intake of alcohol was associated with
an increase in overall breast cancer risk only among
women with BMI ≤25 kg/m2. It suggests that alcohol and
obesity may not act as an additive manner on the breast
cancer risk among pre-menopausal women. We also ob-
served statistically significant effect modification of alco-
hol by body mass index on ER-/PR- breast cancer risk.
Three cohort studies reported similar results [15–17].
In both the EPIC study and the epidemiologic follow-up
to the first National Health and Nutrition Examination
Study (NHANES), the elevated risk by alcohol consump-
tion was most prominent among both pre- and post-
menopausal lean women (BMI <18.5 kg/m2 in EPIC
and <22.5 kg/m2 in NHANES). In the California Teachers
Study Cohort, normal weight or marginally overweight
women (BMI < 27.3 kg/m2) whose alcohol consumption
level was ≥ 20 g/day showed 40 % higher risk for breast
Table 1 Baseline characteristics of the Swedish Women’s Lifestyle and Health study participants according to alcohol intake
Alcohol intake (g/day)
0 0.1–5 5.1–15 >15
No. of participans 10,153 22,249 11,734 1,097
Age at enrollment (mean) 39.8 39.7 40.5 41.4
Educational attainment >11 years, (%) 46.3 56.3 61.4 61.7
History of breast cancer in mother and/or sister (%) 4.2 4.2 5.3 5.9
Smoking habits (%)
Never 50.5 43.0 32.0 18.1
Former 28.2 35.3 40.7 40.7
Current 21.3 21.7 27.3 41.2
Age at menarche (mean) 12.9 13.0 13.0 13.1
Women with more than 3 children (%) 32.5 27.2 24.0 23.4
Age at first child birth among parous women (mean) 23.5 24.0 24.1 23.8
Total duration of breast feeding (months) 30.9 30.8 30.2 30.3
Ever oral contraceptive use (%) 75.1 85.0 88.2 89.7
Post-menopause (%) 4.4 3.8 4.3 3.7
Body mass index (>25 kg/m2, %) 31.9 24.1 21.1 24.6
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cancer compared with nondrinking normal weight or
marginally overweight women (95 % CI 1.10–1.80) [15].
The RR for nondrinking obese women was 1.21 (95 % CI
0.96–1.53), and that for obese women with ≥ 20 g/day al-
cohol consumption was 1.33 (95 % CI 0.87–2.04). Several
case–control studies also suggested effect modification
by body mass index, with the effect of moderate alcohol
consumption limited to women with low or normal
BMI [18, 19]. In a pooled-analysis, however, no signifi-
cant effect modification by body mass index on the as-
sociation between alcohol consumption and breast
cancer risk was found [20, 21].
Alcohol and obesity probably share common biological
mechanisms in breast carcinogenesis through circulating
sex hormone levels. Both alcohol consumption and
obesity measures (BMI and waist-hip ratio) were associ-
ated with circulating hormones, especially SHBG in a
cross-sectional study [22]. The variation in SHBG was,
however, larger by BMI groups (54.1 nmol/L for <20 kg/
m2 vs. 31.7 nmol/L for >27.5 kg/m2) than by alcohol
consumption level (51.1 nmol/L for non-drinker vs.
43.7 nmol/L for ≥ 16 g/day). We postulate that obese
women whose SHBG level is already decreased may be
less affected by alcohol intake.
Previous epidemiological studies reported associations
between alcohol consumption and ER+ breast tumors,
whereas weak or null associations were observed for ER-
tumors [23]. The strongest association was observed for
ER+/PR- tumors [23]. While the results were not statisti-
cally significant, the pattern of the point estimates in our
study is similar to the previous meta-analysis. The
mechanisms of stronger association between alcohol
consumption and ER+/PR- tumors than ER+/PR+ are
unknown. Although limited by low statistical power in
the stratified analysis by hormonal receptor status, ele-
vated breast cancer risk with higher alcohol consump-
tion was observed for low BMI groups regardless of
hormone receptor status of the tumor in our study. In
addition, elevated risk with higher alcohol consumption
among low BMI group and the highest relative risk
among obese non-drinkers for ER-/PR- breast cancer
suggested a potential interaction between alcohol intake
and ER-/PR- tumors by BMI. This finding should be
investigated further in other epidemiological studies.
Ovarian hormones are essential for development of both
hormone-dependent and hormone-independent breast
tumors [24]. Controlled feeding studies suggest that al-
cohol intake increases circulating estrogen levels in both
premenopausal [25–27] and postmenopausal women
[28–31]. In contrast, moderate alcohol consumption is
also linked to lower progesterone concentration in pre-
menopausal women [26]. Proposed mechanisms of by
which alcohol intake effects estrogen levels include an in-
creased rate of aromatization of testosterone or a de-
creased rate of oxidation of estradiol to estrone [32].
However, only a few studies have reported alcohol con-
sumption, body mass index and endogenous female hor-
mone concentrations simultaneously in postmenopausal
women [20, 33]. In our analysis, additional adjustment for
exogenous hormone use did not change the association
between alcohol consumption and breast cancer risk.
Further study with comprehensive assessment of hormone
Table 2 Alcohol intake and risk of breast cancer by hormone receptor status in the Swedish Women’s Lifestyle and Health study
Alcohol intake (g/day) Total 0 0.1–5 5.1–15 >15 Per 5 g/day increase
No. of participants 45,233 10,153 22,249 11,734 1,097
Person-year 758,430 151,813 354,589 221,531 30,497
Total breast cancer (No.) 1,385 276 646 421 42
RR (95 % CI)- unadjusted 1.0 1.07 (0.92–1.25) 1.24 (1.06–1.45) 1.29 (0.99–1.67) 1.02 (1.00–1.04)
RR (95 % CI)- adjusted 1.0 1.03 (0.89–1.20) 1.16 (0.99–1.36) 1.17 (0.90–1.53) 1.01 (0.98–1.04)
ER(+)/PR(+) breast cancer (No.) 718 140 353 205 19
RR (95 % CI)- unadjusted 1.0 1.17 (0.95–1.46) 1.25 (1.00–1.56) 1.21 (0.83–1.77) 1.02 (0.98–1.05)
RR (95 % CI)- adjusted 1.0 1.13 (0.91–1.40) 1.17 (0.93–1.47) 1.11 (0.76–1.63) 1.01 (0.97–1.05)
ER(+)/PR(−) breast cancer (No.) 196 39 88 65 4
RR (95 % CI)- unadjusted 1.0 0.99 (0.66–1.50) 1.31 (0.87–1.99) 1.04 (0.51–2.15) 1.01 (0.95–1.08)
RR (95 % CI)- adjusted 1.0 1.00 (0.66–1.51) 1.35 (0.89–2.06) 1.09 (0.53–2.25) 1.02 (0.95–1.08)
ER(−)/PR(−) breast cancer (No.) 187 45 83 51 8
RR (95 % CI)- unadjusted 1.0 0.95 (0.64–1.42) 1.03 (0.67–1.57) 1.27 (0.64–2.52) 1.01 (0.92–1.10)
RR (95 % CI)- adjusted 1.0 0.90 (0.60–1.33) 0.91 (0.59–1.39) 1.04 (0.52–2.08) 0.98 (0.87–1.33)
Adjusted models were adjusted for educational attainment (0–11 years/>11 years), history of breast cancer in mother and/or sister (Yes/No), smoking habits
(current/former/never smokers), age at menarche (years), parity at baseline (0, 1, 2, 3, and >3), age at the first child birth (years), total breast feeding duration
(months), and oral contraceptive use (current/former/never)
RR relative risk, CI confidence interval, ER estrogen receptor, PR progesterone receptor
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levels and adiposity measures would help to explain the
mechanisms of the excess risk of alcohol consumption in
lean premenopausal women.
Strengths of our study include its prospective design,
which minimizes potential for recall bias. Potential con-
founders of the association between alcohol consumption
and breast cancer risk, such as family history of breast
cancer, were adjusted for in the multivariate model. Breast
cancer ascertainment by linkage to the registries ensures
virtually complete follow-up. In addition, information on
hormone receptor status was available for most of breast
cancer patients with relatively high completeness. Another
strength is the age structure of the cohort, since few
cohort studies aimed to include predominantly premeno-
pausal women [14].
Limitation of the study includes that information on
alcohol consumption was assessed at baseline and follow-
up surveys and may not accurately reflect long- term con-
sumption habit. Analysis by hormone receptor status may
lack statistical power due to small numbers of cases in
each exposure groups.
Conclusions
In conclusion, an increase in breast cancer risk with
higher alcohol consumption was found for all breast can-
cers only among women with a BMI ≤25 kg/m2. The com-
peting effects of obesity and alcohol consumption on
circulating sex hormone levels may explain the results.
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Table 3 Relative risks (RR) and their 95 % confidence intervals (CI) on the association between alcohol intake and breast cancer risk
by body mass index (BMI) in the Swedish Women’s Lifestyle and Health study
BMI
<=25 kg/m2 >25 kg/m2
Alcohol intake (g/day) No. of cases RR (95 % CI) No. of cases RR (95 % CI) p-interaction
Total breast cancer (n = 1,385)
0 150 1.0 86 0.99 (0.76–1.29) 0.59
0.1–5 418 1.05 (0.87–1.26) 181 1.00 (0.80–1.24)
5.1–15 339 1.19 (0.98–1.44) 135 1.08 (0.86–1.37)
> 15 56 1.32 (0.97–1.81) 20 0.88 (0.55–1.41)
Per 5 g/day increase 1.03 (1.00–1.05) 0.96 (0.88–1.04)
ER(+)/PR(+) breast cancer (n = 718)
0 71 1.0 46 1.08 (0.75–1.57) 0.69
0.1–5 217 1.14 (0.87–1.49) 109 1.23 (0.91–1.66)
5.1–15 167 1.22 (0.92–1.61) 72 1.18 (0.85–1.65)
> 15 26 1.28 (0.81–2.03) 10 0.90 (0.46–1.76)
Per 5 g/day increase 1.03 (0.99–1.06) 0.93 (0.83–1.05)
ER(+)/PR(−) breast cancer (n = 196)
0 23 1.0 10 0.69 (0.33–1.45) 0.98
0.1–5 55 0.94 (0.58–1.53) 23 0.77 (0.43–1.39)
5.1–15 55 1.29 (0.79–2.13) 20 0.98 (0.53–1.81)
> 15 7 1.06 (0.45–2.50) 3 0.80 (0.24–2.69)
Per 5 g/day increase 1.02 (0.96–1.09) 0.98 (0.82–1.18)
ER(−)/PR(−) breast cancer (n = 187)
0 17 1.0 19 1.95 (1.01–3.76) 0.04
0.1–5 60 1.29 (0.75–2.22) 21 1.01 (0.53–1.93)
5.1-15 44 1.31 (0.74–2.30) 15 1.03 (0.51–2.08)
> 15 10 1.96 (0.89–4.34) 1 0.36 (0.05–2.74)
Per 5 g/day increase 1.02 (0.94–1.11) 0.80 (0.59–1.09)
Adjusted models were adjusted for educational attainment (0–11 years/>11 years), history of breast cancer in mother and/or sister (Yes/No), smoking habits
(current/former/never smokers), age at menarche (years), parity at baseline (0, 1, 2, 3, and >3), age at the first child birth (years), total breast feeding duration
(months), and oral contraceptive use (current/former/never)
ER estrogen receptor, PR progesterone receptor
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